You need to sign in or sign up before continuing.
Monitoring platform for Belgian Market Access

Every Belgian market access event for your medicines, on one timeline.

Farmanaut tracks regulatory, early-access, CTG, pricing and reimbursement events for your portfolio and your competitors. Get proactive alerts on changes and understand historical market access trajectories.

See what Farmanaut does

See competitor moves before they reach your market

Every step towards access in Belgium leaves a trace: an early-access programme, a positive EMA opinion, an authorisation, a CTG/CRM agenda item, a reimbursement decision. Farmanaut connects those traces per medicine, so you see where a competitor is heading.

For innovative, generic or biosimilar pharma companies.

  • Early: an alert at the first step, from a new early-access programme to an item on the CTG agenda.
  • Complete: the full access trajectory per medicine, with price and reimbursement history.
  • Verifiable: every event linked to its official source, ready to use in your own analysis.
What Farmanaut does

Follow what changes and understand market access trajectories.

Your one-stop shop for official source data

Daily actualized and official data from FAMHP, EMA, CRM, NIHDI and SAM, brought together per medicine.

Monitor what’s moving

Follow medicines, APIs and competitor portfolios and get proactive alerts on regulatory, early-access, CTG and reimbursement developments, down to the smallest step in a competitor’s access timeline and changes to reimbursement criteria in CIVARS. Receive comprehensive proactive market access updates directly in your mailbox and check changes before effective.

From CTG negotiation to price and reimbursement

Follow each CTG/CRM procedure from agenda item to outcome: the reimbursement decision and the price that followed. See how competitor negotiations progress, how long they take and where they end, alongside the full price and reimbursement history per medicine.

“I was amazed by the simplicity of Farmanaut and immediately started following molecules.”

Commercial Strategy Manager

“I am very happy with Farmanaut, it’s very convenient to find all the latest information and history in one intuitive tool.”

Market Access Manager

“Investing in Farmanaut is a no-brainer compared to the cost of hiring a part time collaborator.”

Head of Market Access
New in Farmanaut

Early-access programmes now on the timeline

Farmanaut now follows fagg compassionate use (CUP) and medical need programmes (MNP). You see when a competitor starts, modifies or stops an early-access programme, next to the other milestones of that medicine.

New signals, where you already work.

  • On each medicine’s overview: see ongoing programmes, indications and references to the original fagg documentation.
  • On the timeline: see programme starts, stops, resumptions and modifications.
  • In your alerts: if you already follow authorisation events, programme changes are included automatically. You can switch them off per medicine.
Existing users: nothing to set up. Programme events appear in the monitoring you already have.

Changes are reported when detected. Historical start dates are based on available source documentation; official closing dates are not always provided. Illustrative screenshots are from the Dutch-language interface.

Farmanaut timeline showing a new medical need programme event
A programme becomes a dated event on the medicine’s timeline.
Farmanaut medicine overview listing the medical need programme
Programme details are linked directly from the brand overview.
In development · Limited pilot participation

Help shape CTG Intelligence.

We are uncovering what CTG assessment reports reveal about reimbursement trajectories: recurring assessment concerns, company responses and the impact on patient access. The goal is to make them easy to analyse and compare. Tell us which therapeutic area you want analysed, and we explore it with you in a focused pilot.

Curious what Farmanaut could do for your team?

Request a trial

Built by Digile, the Belgian team behind the public SAM viewer.